twitter Tweet

Dr. Shinto and colleagues test new fish oil/lipoic acid combination as Alzheimer’s treatment

Pioneering clinical trial examines whether fish oil and lipoic acid combination slows cognitive and functional decline associated with Alzheimer’s disease

Oregon Health & Science University researchers are expanding a study that found a combination of dietary supplements slows the cognitive and functional decline associated with Alzheimer’s disease. The results may help enable people with mild to moderate Alzheimer’s to live independently.

The new clinical trial will involve 100 participants in Portland, Bend, Medford and Klamath Falls   who will receive either a combination of lipoic acid and fish oil or a placebo. An earlier pilot study demonstrated that the combination of these dietary supplements slows the mental decline of Alzheimer’s patients.

The complete OHSU media release is available online.

Previous Story Dr. Keller and preclinical therapeutics team recently awarded a Joanna McAfee Childhood Cancer Foundation grant Next Story Why I Teach – Suzanne Mitchell, PhD